Table 2.
Methods | Microorganism | Product | Effect | Ref. |
---|---|---|---|---|
Engineering Self-Resistance | S. peucetius | Doxorubicin, Daunorubicin | Enhance | [93] |
S. avermitilis | Avermectin, | Enhance | [94] | |
S. coelicolor | Actinorhodin | Enhance | [95] | |
Regulatory Engineering | ||||
Delete repressor AbsA2~P | S. coelicolor | Actinorhodin, Undecylprodigiosin, Calcium-dependent antibiotic | Enhance | [96] |
Overexpress AverR/StrR | S. avermitilis | Avermectin | Enhance | [97] |
Overexpress AverR/StrR | S. griseous | Streptomycin | Enhance | [98] |
Overexpress SamR0484 | S. ambofaciens | Stambomicin A-D | Cryptic | [99] |
Delete repressor cmmRII | S. griseus | Chromomycin | Enhance | [100] |
Delete repressor AlpW | S. ambofaciens | Alpomycin | Enhance | [101] |
Heterologous Expression | S. avermitilis | Streptomycin | Enhance | [102] |
S. coelicolor | Chloramphenicol | Enhance | [103] | |
S. coelicolor | Congocidine | Enhance | [103] | |
S. cyaneus | CECT 3335 laccase | Enhance | [27] | |
S. lividans TK24 | Mithramycin A | Enhance | [104] | |
Streptomyces sp. | Neothioviridamide | Cryptic | [105] | |
Several wild-type | Siamycin-I | Cryptic | [29] | |
Combinatorial Biosynthesis | S. albus J1074 | Novel paulomycin | Cryptic | [31] |
See table 1 in ref. | [30] | |||
Conditioning Morphology (PCD + MII) | S. albus | Apigenin, Luteolin | Enhance | [15] |
S. mobarensis | Microbial transglutaminase | Enhance | [14] |